By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
In a surgical process called keratoprosthetics, an artificial cornea is used to replace the defective one.
Traditionally, keratoprosthetics is advised following the failure of one or more donor corneal transplants in a patient. he complete thickness of the cornea is removed during the keratoprosthetics implantation surgery, and a synthetic cornea is then implanted in its place.
The Boston Type I Keratoprosthetics is the one that is now utilized the most in the US. It consists of a corneal graft sandwiched between a clear plastic polymethylmethacrylate (PMMA) optic and back plate and locked in place with a titanium locking ring .
The host cornea is trephined partially after the gadget has been put together. The patient’s cornea is then completely resected using curved corneal scissors.
The host tissue is subsequently stitched to the keratoprosthetics using interrupted or flowing sutures. Patients who have had a history of several unsuccessful PKs are typically candidates for a keratoprosthetics transplant.
Ocular surface disease or severe keratitis are two more warning signs. During the procedure, the eye is kept open with the aid of an eyelid speculum. The eye may be given some lubricant to keep it from drying out.
The procedure may involve either a full thickness replacement of the cornea or the implantation of an interlamellar implant, depending on the type of keratoprosthetics being utilized.
For the Alpha or, a punch is utilized to make an opening through the posterior cornea into the anterior chamber and a manual incision is performed to establish a corneal pocket.
Global Keratoprosthetics Market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
The Chinese organization responsible for regulating medicines and medical devices, NMPA, gave the keratoprosthetics its seal of approval for listing.
The MIOK Keratoprosthetics is the first artificial cornea ever approved by the world’s regulatory bodies that does not require the co-implantation of donor corneas.
It is of great significance for the 60 million patients worldwide who suffer from corneal blindness because it makes it possible to restore sight to these patients and lessen the burden on their families.
One of the most important methods for treating people with corneal blindness is corneal transplantation.
However, there is a substantial chance of corneal grafting failures and other postoperative problems, typically as a result of the intricate immune reactions to organ incompatibility.
Such dangers cannot be avoided with other artificial corneas that call for co-implantation of donor corneas.
